{
  "nodes": [
    {
      "gruppering": "Drugs",
      "ecosystem": "BioVentureHub",
      "company_name": "BioVentureHub",
      "id": "BioVentureHub",
      "turnover_sek": 1730000,
      "amount_of_employees": 300,
      "keywords": "",
      "type_of_company": "",
      "operational_focus": "",
      "value_chain": "",
      "therapy_areas": "",
      "area": "",
      "financing": "",
      "ceo": "",
      "company_website": "",
      "company_linkedIn": "",
      "size_in_visualisation": "big",
      "image_path": "images/bioventurehub2.jpg"
    },
    {
      "gruppering": "Drugs",
      "ecosystem": "GoCo",
      "company_name": "GoCo",
      "id": "GoCo",
      "turnover_sek": 1730000,
      "amount_of_employees": 300,
      "keywords": "",
      "type_of_company": "",
      "operational_focus": "",
      "value_chain": "",
      "therapy_areas": "",
      "area": "",
      "financing": "",
      "ceo": "",
      "company_website": "",
      "company_linkedIn": "",
      "size_in_visualisation": "big",
      "image_path": "images/goco.png"
    },
    {
      "gruppering": "Drugs",
      "ecosystem": "Astra",
      "company_name": "AstraZeneca",
      "id": "Astra",
      "turnover_sek": 1730000,
      "amount_of_employees": 300,
      "keywords": "",
      "type_of_company": "",
      "operational_focus": "",
      "value_chain": "",
      "therapy_areas": "",
      "area": "",
      "financing": "",
      "ceo": "",
      "company_website": "",
      "company_linkedIn": "",
      "size_in_visualisation": "big",
      "image_path": "images/astra.png"
    },
    {
      "gruppering": "Drugs",
      "ecosystem": "BioVentureHub",
      "company_name": "Alzinova",
      "id": "Alzinova",
      "turnover_sek": 1730000,
      "amount_of_employees": 3,
      "keywords": "Alzheimer disease, AβCC peptide™ technology",
      "type_of_company": "Drugs",
      "operational_focus": "R&D",
      "value_chain": "Discovery",
      "therapy_areas": "Neurology",
      "area": "Alzheimers",
      "financing": "Listed",
      "ceo": "Torfgård, Kristina",
      "company_logo": "https://www.azbioventurehub.com/content/dam/bioventurehub/images/logo/Alzinova%20logo900x400.png/jcr:content/renditions/cq5dam.web.320.Alzinova%20logo900x400.png",
      "company_website": "https://www.alzinova.com//",
      "company_linkedIn": "https://www.linkedin.com//company//alzinova-ab//",
      "size_in_visualisation": "medium",
      "image_path": "images/alzinova.png"
    },
    {
      "gruppering": "Diagnostics",
      "ecosystem": "BioVentureHub",
      "company_name": "Antaros Medical",
      "id": "Antaros_Medical",
      "turnover_sek": 116000000,
      "amount_of_employees": 75,
      "keywords": "imaging solutions, human clinical studies, CVRM, ONC, repiratory and neuroscience",
      "type_of_company": "Diagnostics, Expert Providers",
      "operationa_focus": "R&D",
      "value_chain": "Discovery",
      "therapy_areas": "CVRM, Oncology, R&I, Neuro",
      "area": "Imaging",
      "financing": "Private",
      "ceo": "Hulthe, Johannes",
      "company_logo": "https://www.azbioventurehub.com/content/dam/bioventurehub/images/logo/Antaros-Medical.jpg/jcr:content/renditions/cq5dam.web.320.Antaros-Medical.jpg",
      "image_path": "images/Antaros-Medical.jpg",
      "company_website": "https://antarosmedical.com/",
      "company_linkedin": "https://www.linkedin.com/company/antaros-medical/",
      "size_in_visualisation": "medium"
    },
    {
      "gruppering": "Drugs",
      "ecosystem": "BioVentureHub",
      "company_name": "Cereno Scientific",
      "id": "Cereno_Scientific",
      "turnover_sek": 44800000,
      "amount_of_employees": 1,
      "type_of_company": "Drugs",
      "operationa_focus": "R&D",
      "value_chain": "Research",
      "therapy_areas": "Cardiovascular disease",
      "area": "Cardiovascular",
      "financing": "Listed",
      "ceo": "Sörensen, Sten",
      "company_logo": "https://www.azbioventurehub.com/content/dam/bioventurehub/images/logo/Cereno-logo.png/jcr:content/renditions/cq5dam.web.320.Cereno-logo.png",
      "company_website": "https://cerenoscientific.com/",
      "company_linkedin": "https://www.linkedin.com//company//cereno-scientific-ab//",
      "size_in_visualisation": "medium",
      "image_path": "images/cereno.png"
    },
    {
      "gruppering": "Drugs",
      "ecosystem": "BioVentureHub",
      "company_name": "Corline Biomedical",
      "id": "Corline_Biomedical",
      "turnover_sek": 17300000,
      "amount_of_employees": 9,
      "type_of_company": "Drugs, Med Tech",
      "operationa_focus": "R&D",
      "value_chain": "Research",
      "therapy_areas": "Transplantation, Regenerative Medicine",
      "area": "Diabetes",
      "financing": "Listed",
      "ceo": "Nittmar, Henrik",
      "company_logo": "https://www.azbioventurehub.com/content/dam/bioventurehub/images/logo/corline-biomedical.jpg/jcr:content/renditions/cq5dam.web.320.corline-biomedical.jpg",
      "image_path": "images/Corline-Biomedical.jpg",
      "company_website": "https://www.corline.se/home",
      "size_in_visualisation": "medium"
    },
    {
      "gruppering": "Drugs",
      "ecosystem": "BioVentureHub",
      "company_name": "Emeriti Bio",
      "id": "Emeriti_Bio",
      "turnover_sek": 3300000,
      "amount_of_employees": 2,
      "type_of_company": "Drugs",
      "operationa_focus": "R&D",
      "value_chain": "Discovery",
      "therapy_areas": "Respiratory (with Vicore) & Cardiovascular Disease (with Cereno Scientific)",
      "area": "Gastrointestinal",
      "financing": "Private",
      "ceo": "Fryklund, Jan",
      "company_logo": "https://www.azbioventurehub.com/content/dam/bioventurehub/images/logo/Emeriti-Bio.jpg/jcr:content/renditions/cq5dam.web.320.Emeriti-Bio.jpg",
      "company_website": "https://www.emeritibio.se/",
      "company_linkedin": "LinkedIn Missing",
      "size_in_visualisation": "medium",
      "image_path": "images/emirit_bio.jpg"
    },
    {
      "gruppering": "Drugs",
      "ecosystem": "BioVentureHub",
      "company_name": "Mendus",
      "id": "Mendus",
      "turnover_sek": 0,
      "amount_of_employees": 30,
      "type_of_company": "Drugs",
      "operationa_focus": "R&D",
      "value_chain": "Discovery",
      "therapy_areas": "Oncology",
      "area": "Oncology",
      "financing": "Listed",
      "ceo": "Manting, Erik Hans",
      "company_logo": "https://www.azbioventurehub.com/content/dam/bioventurehub/images/Aboutus/mendus1.JPG/jcr:content/renditions/cq5dam.web.320.mendus1.JPG",
      "company_website": "https://mendus.com/",
      "company_linkedin": "https://www.linkedin.com//company//mendus//",
      "size_in_visualisation": "medium",
      "image_path": "images/mendus.jpg"
    },
    {
      "gruppering": "Device",
      "ecosystem": "BioVentureHub",
      "company_name": "Mölnlycke Health Care",
      "id": "Mölnlycke_Health_Care",
      "turnover_sek": 14400000000,
      "amount_of_employees": 462,
      "type_of_company": "Med Tech",
      "operationa_focus": "Commercial",
      "value_chain": "Market",
      "therapy_areas": "Dermatology & Wound",
      "area": "Wound care",
      "financing": "Private (99% owned by Patricia Industries – part of Investor AB)",
      "ceo": "Rihter, Zlatko",
      "company_logo": "https://www.azbioventurehub.com/content/dam/bioventurehub/images/logo/Molnlycke.jpg/jcr:content/renditions/cq5dam.web.320.Molnlycke.jpg",
      "image_path": "images/molnlycke.jpg",
      "company_website": "https://www.molnlycke.com/",
      "company_linkedin": "https://www.linkedin.com/company/molnlyckehealthcare/",
      "size_in_visualisation": "medium"
    },
    {
      "gruppering": "Diagnostics",
      "ecosystem": "BioVentureHub",
      "company_name": "Q&Q Labs",
      "id": "Q&Q_Labs",
      "turnover_sek": 18200000,
      "amount_of_employees": 16,
      "type_of_company": "Expert Providers",
      "operationa_focus": "R&D",
      "value_chain": "Market",
      "therapy_areas": "N/A",
      "area": "Analytics",
      "financing": "Private",
      "ceo": "Wahlström, Rickard",
      "company_logo": "https://www.azbioventurehub.com/content/dam/bioventurehub/images/logo/qqlabs-ab.jpg/jcr:content/renditions/cq5dam.web.320.qqlabs-ab.jpg",
      "company_website": "https://qandqlabs.se//",
      "company_linkedin": "https://www.linkedin.com//company//q&q-labs-ab//",
      "size_in_visualisation": "medium",
      "image_path": "images/q&q.jpg"
    },
    {
      "gruppering": "Device",
      "ecosystem": "BioVentureHub",
      "company_name": "Waters Sverige",
      "id": "Waters_Sverige",
      "turnover_sek": 343000000,
      "amount_of_employees": 61,
      "type_of_company": "Expert Providers",
      "operationa_focus": "R&D",
      "value_chain": "Market",
      "therapy_areas": "N/A",
      "area": "Analytics",
      "financing": "Listed",
      "ceo": "Turner, Christina Charlotte Lindved",
      "company_logo": "https://media.licdn.com/dms/image/D4E0BAQEARO58xA-kOQ/company-logo_200_200/0/1688172998415?e=1696464000&v=beta&t=oEggaf4YXU77I9lJMU6wVuyN9WdCgStn-CCw1SWLxs4",
      "image_path": "images/Waters.jpg",
      "company_website": "https://www.waters.com/nextgen/se/en.html",
      "company_linkedin": "https://www.linkedin.com/company/waters/",
      "size_in_visualisation": "medium"
    },
    {
      "gruppering": "Digital",
      "ecosystem": "BioVentureHub",
      "company_name": "Albus Health",
      "id": "Albus_Health",
      "turnover_sek": 2500000,
      "amount_of_employees": 4,
      "keywords": "contactless nocturnal device, respiratory rate, coughair quality, Biomarkers",
      "type_of_company": "Med Tech, Digital",
      "operationa_focus": "R&D",
      "value_chain": "Market",
      "therapy_areas": "Respiratory",
      "area": "Respiratory",
      "financing": "Private",
      "ceo": "Udani, Mikesh",
      "company_logo": "https://media.licdn.com/dms/image/C4E0BAQG8fm5Gwqngyw/company-logo_200_200/0/1567093418232?e=1696464000&v=beta&t=2KS-lBTJt5ULqmmDGjxOPpeyG45Opq1KwRA8nDsi9xM",
      "image_path": "images/albus_health.jpg",
      "company_website": "https://albushealth.com/",
      "company_linkedin": "https://www.linkedin.com/company/albushealth/",
      "size_in_visualisation": "medium"
    },
    {
      "gruppering": "Diagnostics",
      "ecosystem": "BioVentureHub",
      "company_name": "Amferia",
      "id": "Amferia",
      "turnover_sek": 1400000,
      "amount_of_employees": 5,
      "keywords": "antibacterial material, patented technology, wound care product",
      "type_of_company": "Med Tech",
      "operationa_focus": "R&D",
      "value_chain": "Market",
      "therapy_areas": "Dermatology & Wound, Infection",
      "area": "Antimicrobial",
      "financing": "Private",
      "ceo": "Rajasekaran, Anand",
      "company_logo": "https://www.azbioventurehub.com/content/dam/bioventurehub/images/logo/Amferia%20Header.png/jcr:content/renditions/cq5dam.web.320.Amferia%20Header.png",
      "company_website": "https://www.amferia.com//",
      "company_linkedin": "https://www.linkedin.com//company//amferia//",
      "size_in_visualisation": "medium",
      "image_path": "images/amferia.png"
    },
    {
      "gruppering": "Drugs",
      "ecosystem": "BioVentureHub",
      "company_name": "Apconix",
      "id": "Apconix",
      "turnover_sek": 0,
      "amount_of_employees": 1,
      "keywords": "Consultation opportunity for Clinical Pharmacology & Safety Sciences",
      "type_of_company": "Expert Providers",
      "operationa_focus": "R&D",
      "value_chain": "Research",
      "therapy_areas": "N/A",
      "area": "Safety",
      "financing": "Private",
      "ceo": "Knight, Richard",
      "company_logo": "https://www.azbioventurehub.com/content/dam/bioventurehub/images/logo/Apconix.jpg/jcr:content/renditions/cq5dam.web.320.Apconix.jpg",
      "image_path": "images/apconix.jpg",
      "company_website": "https://www.apconix.com/",
      "company_linkedin": "https://www.linkedin.com/company/apconix/",
      "size_in_visualisation": "medium"
    },
    {
      "gruppering": "Drugs",
      "ecosystem": "BioVentureHub",
      "company_name": "Betagenon",
      "id": "Betagenon",
      "turnover_sek": 7900000,
      "amount_of_employees": 3,
      "type_of_company": "Drugs",
      "operationa_focus": "R&D",
      "value_chain": "Discovery",
      "therapy_areas": "CVRM",
      "area": "Aging",
      "financing": "Private",
      "ceo": "Hall, James",
      "company_logo": "https://www.azbioventurehub.com/content/dam/bioventurehub/images/logo/Betagenon_logoo.jpg/jcr:content/renditions/cq5dam.web.320.Betagenon_logoo.jpg",
      "company_website": "Missing",
      "company_linkedin": "LinkedIn Missing",
      "size_in_visualisation": "medium",
      "image_path": "images/betagenon.jpg"
    },
    {
      "gruppering": "Diagnostics",
      "ecosystem": "BioVentureHub",
      "company_name": "Cline Scientific",
      "id": "Cline_Scientific",
      "turnover_sek": 2900000,
      "amount_of_employees": 2,
      "type_of_company": "Med Tech, Diagnostics",
      "operationa_focus": "R&D",
      "value_chain": "Research",
      "therapy_areas": "N/A/ Oncology",
      "area": "Oncology",
      "financing": "Listed",
      "ceo": "Sundh, Patrik",
      "company_logo": "https://www.azbioventurehub.com/content/dam/bioventurehub/images/logo/cline-ab.jpg/jcr:content/renditions/cq5dam.web.320.cline-ab.jpg",
      "company_website": "https://www.clinescientific.com//",
      "company_linkedin": "https://www.linkedin.com//company//cline-technologies//",
      "size_in_visualisation": "medium",
      "image_path": "images/cline.jpg"
    },
    {
      "gruppering": "Digital",
      "ecosystem": "BioVentureHub",
      "company_name": "Datametrix",
      "id": "Datametrix",
      "turnover_sek": 280000000,
      "amount_of_employees": 1,
      "type_of_company": "Digital, Expert Providers",
      "operationa_focus": "Commercial",
      "value_chain": "Discovery",
      "therapy_areas": "N/A",
      "area": "Digital",
      "financing": "Private",
      "ceo": "El Rhali, Ahmed",
      "company_logo": "https://www.azbioventurehub.com/content/dam/bioventurehub/images/logo/data-metrix.jpg/jcr:content/renditions/cq5dam.web.320.data-metrix.jpg",
      "image_path": "images/datametrix.jpg",
      "company_website": "https://datametrix.ch/",
      "company_linkedin": "https://www.linkedin.com/company/datametrix-ag/",
      "size_in_visualisation": "medium"
    },
    {
      "gruppering": "Drugs",
      "ecosystem": "BioVentureHub",
      "company_name": "Ectin Research",
      "id": "Ectin_Research",
      "turnover_sek": 2200000,
      "amount_of_employees": 1,
      "type_of_company": "Drugs",
      "operationa_focus": "R&D",
      "value_chain": "Discovery",
      "therapy_areas": "Oncology",
      "area": "Oncology",
      "financing": "Listed",
      "ceo": "Sjöblom-Hallén, Anna",
      "company_logo": "https://www.azbioventurehub.com/content/dam/bioventurehub/images/logo/Ectin%20Research%20logo%20dec%202020.png/jcr:content/renditions/cq5dam.web.320.Ectin%20Research%20logo%20dec%202020.png",
      "company_website": "https://www.ectinresearch.com//",
      "company_linkedin": "https://www.linkedin.com//company//ectin-research//",
      "size_in_visualisation": "medium",
      "image_path": "images/ectin.png"
    },
    {
      "gruppering": "Drugs",
      "ecosystem": "BioVentureHub",
      "company_name": "Inorbittx",
      "id": "Inorbittx",
      "turnover_sek": 5200000,
      "amount_of_employees": 1,
      "type_of_company": "Drugs",
      "operationa_focus": "R&D",
      "value_chain": "Research",
      "therapy_areas": "CVRM, with focus on NASH",
      "area": "Cardiovascular",
      "financing": "Private",
      "ceo": "Benthem, Bert",
      "company_logo": "https://www.azbioventurehub.com/content/dam/bioventurehub/images/logo/inorbittx.jpg/jcr:content/renditions/cq5dam.web.320.inorbittx.jpg",
      "company_website": "https://inorbittx.com/",
      "company_linkedin": "LinkedIn Missing",
      "size_in_visualisation": "medium",
      "image_path": "images/inorbittx.jpg"
    },
    {
      "gruppering": "Device",
      "ecosystem": "BioVentureHub",
      "company_name": "In Singulo Solutions",
      "id": "In_Singulo_Solutions",
      "turnover_sek": 1100000,
      "amount_of_employees": 1,
      "type_of_company": "Med Tech",
      "operationa_focus": "R&D",
      "value_chain": "Research",
      "therapy_areas": "N/A",
      "area": "Analytics",
      "financing": "Private",
      "ceo": "Holm, Karl-Johan",
      "company_logo": "https://www.azbioventurehub.com/content/dam/bioventurehub/images/logo/Insingulo-new-logo.png/jcr:content/renditions/cq5dam.web.320.Insingulo-new-logo.png",
      "company_website": "https://insingulo.com//",
      "company_linkedin": "https://www.linkedin.com//company//insingulo-ab//",
      "size_in_visualisation": "medium",
      "image_path": "images/insingula.png"
    },
    {
      "gruppering": "Digital",
      "ecosystem": "BioVentureHub",
      "company_name": "Intelligent Implants",
      "id": "Intelligent_Implants",
      "turnover_sek": 7900000,
      "amount_of_employees": 7,
      "type_of_company": "Med Tech, Digital",
      "operationa_focus": "R&D",
      "value_chain": "Market",
      "therapy_areas": "Orthopaedic",
      "area": "Digital",
      "financing": "Private",
      "ceo": "Zellmer, John",
      "company_logo": "https://www.azbioventurehub.com/content/dam/bioventurehub/images/logo/Intelligents_implants_logo_COLOR.png/jcr:content/renditions/cq5dam.web.320.Intelligents_implants_logo_COLOR.png",
      "company_website": "https://intelligentimplants.ie//",
      "company_linkedin": "https://www.linkedin.com//company//intelligent-implants//",
      "size_in_visualisation": "medium",
      "image_path": "images/intelligent_implants.png"
    },
    {
      "gruppering": "Drugs",
      "ecosystem": "BioVentureHub",
      "company_name": "I-Tech",
      "id": "I-Tech",
      "turnover_sek": 53500000,
      "amount_of_employees": 9,
      "type_of_company": "Med Tech",
      "operationa_focus": "Commercial",
      "value_chain": "Market",
      "therapy_areas": "N/A",
      "area": "Antifouling",
      "financing": "Listed",
      "ceo": "Chaabane, Philip",
      "company_logo": "https://www.azbioventurehub.com/content/dam/bioventurehub/images/logo/i-tech.jpg/jcr:content/renditions/cq5dam.web.320.i-tech.jpg",
      "image_path": "images/itech.jpg",
      "company_website": "https://i-tech.se/",
      "company_linkedin": "https://www.linkedin.com/company/i-tech-ab/",
      "size_in_visualisation": "medium"
    },
    {
      "gruppering": "Device",
      "ecosystem": "BioVentureHub",
      "company_name": "Kromnigon",
      "id": "Kromnigon",
      "turnover_sek": 500000,
      "amount_of_employees": 2,
      "type_of_company": "Med Tech",
      "operationa_focus": "Commercial",
      "value_chain": "Research",
      "therapy_areas": "N/A",
      "area": "Analytics",
      "financing": "Private",
      "ceo": "Fogelstrand, Per",
      "company_logo": "https://www.azbioventurehub.com/content/dam/bioventurehub/images/logo/Kromningon%20ny.png/jcr:content/renditions/cq5dam.web.320.Kromningon%20ny.png",
      "company_website": "https://kromnigon.com//",
      "company_linkedin": "https://www.linkedin.com//company//kromnigon-ab//",
      "size_in_visualisation": "medium",
      "image_path": "images/kromnigon.png"
    },
    {
      "gruppering": "Device",
      "ecosystem": "BioVentureHub",
      "company_name": "KTH Nanobiotech",
      "id": "KTH_Nanobiotech",
      "turnover_sek": 14400000,
      "amount_of_employees": 12,
      "type_of_company": "Academia, Med Tech",
      "operationa_focus": "Academia",
      "value_chain": "Research",
      "therapy_areas": "N/A",
      "area": "Nanotechnology",
      "financing": "Private",
      "ceo": "Jönsson, Håkan",
      "company_logo": "https://media.licdn.com/dms/image/C4D0BAQGkcfLVY-zvDA/company-logo_200_200/0/1534319667361?e=1696464000&v=beta&t=BIxif65vuxX7v1_YKsj3hkmT2oOfTEatbNy8Nt5qN1E",
      "image_path": "images/KTH.jpg",
      "company_website": "https://www.kth.se/pro/nanobio/division-of-nanobiotechnology-1.185383",
      "company_linkedin": "https://www.linkedin.com/school/kth/",
      "size_in_visualisation": "medium"
    },
    {
      "gruppering": "Device",
      "ecosystem": "BioVentureHub",
      "company_name": "Lucero",
      "id": "Lucero",
      "turnover_sek": 900000,
      "amount_of_employees": 2,
      "type_of_company": "Med Tech",
      "operationa_focus": "R&D",
      "value_chain": "Research",
      "therapy_areas": "N/A",
      "area": "Analytics",
      "financing": "Private",
      "ceo": "Jacklin, Christopher",
      "company_logo": "https://www.azbioventurehub.com/content/dam/bioventurehub/images/logo/Lucero%20ny.png/jcr:content/renditions/cq5dam.web.480.Lucero%20ny.png",
      "image_path": "images/Lucero.png",
      "company_website": "https://www.lucerobio.com/",
      "company_linkedin": "https://www.linkedin.com/company/lucero/",
      "size_in_visualisation": "medium"
    },
    {
      "gruppering": "Drugs",
      "ecosystem": "BioVentureHub",
      "company_name": "Metabogen",
      "id": "Metabogen",
      "turnover_sek": 1000000,
      "amount_of_employees": 6,
      "type_of_company": "Drugs",
      "operationa_focus": "Commercial",
      "value_chain": "Market",
      "therapy_areas": "Pre-diabetes, Immuno-oncology",
      "area": "Metabolism",
      "financing": "Financed by BioGaia that is listed",
      "ceo": "Malcus, Sara",
      "company_logo": "https://www.azbioventurehub.com/content/dam/bioventurehub/images/logo/Metabogen.jpg/jcr:content/renditions/cq5dam.web.320.Metabogen.jpg",
      "company_website": "https://www.metabogen.se//",
      "company_linkedin": "https://www.linkedin.com//company//metabogen-ab//",
      "size_in_visualisation": "medium",
      "image_path": "images/metabogen.jpg"
    },
    {
      "gruppering": "Device",
      "ecosystem": "BioVentureHub",
      "company_name": "Nanolyze",
      "id": "Nanolyze",
      "turnover_sek": 1400000,
      "amount_of_employees": 2,
      "type_of_company": "Med Tech",
      "operationa_focus": "R&D",
      "value_chain": "Discovery",
      "therapy_areas": "N/A",
      "area": "Analytics",
      "financing": "Private",
      "ceo": "Löfgren, Nils",
      "company_logo": "https://www.azbioventurehub.com/content/dam/bioventurehub/images/logo/Nanolyze_logo-900x400.png/jcr:content/renditions/cq5dam.web.320.Nanolyze_logo-900x400.png",
      "image_path": "images/nanolyze.png",
      "company_website": "https://www.nanolyze.se/",
      "company_linkedin": "https://www.linkedin.com//company/nanolyze/",
      "size_in_visualisation": "medium"
    },
    {
      "gruppering": "Diagnostics",
      "ecosystem": "BioVentureHub",
      "company_name": "CII / Chemical Imaging Infrastructure",
      "id": "CII_//_Chemical_Imaging_Infrastructure",
      "turnover_sek": 2900000,
      "amount_of_employees": 2,
      "type_of_company": "Academia, Med Tech",
      "operationa_focus": "Academia",
      "value_chain": "Research",
      "therapy_areas": "N/A",
      "area": "Imaging",
      "financing": "Private",
      "ceo": "Malmberg, Per",
      "company_logo": "https://www.azbioventurehub.com/content/dam/bioventurehub/images/logo/NanoSIMS_logo_small.png/jcr:content/renditions/cq5dam.web.320.NanoSIMS_logo_small.png",
      "company_website": "N/A https://www.chalmers.se//en//infrastructure//cii//about-us//",
      "company_linkedin": "https://www.linkedin.com//company//chemical-imaging-infrastructure//",
      "size_in_visualisation": "medium",
      "image_path": "images/cii.png"
    },
    {
      "gruppering": "Drugs",
      "ecosystem": "BioVentureHub",
      "company_name": "Oligonova",
      "id": "OligoNova",
      "turnover_sek": 0,
      "amount_of_employees": 7,
      "type_of_company": "Academia, Med Tech",
      "operationa_focus": "Academia",
      "value_chain": "Research",
      "therapy_areas": "N/A",
      "area": "Pharmaceuticals",
      "financing": "Private",
      "ceo": "Matsson, Pär",
      "company_logo": "https://www.azbioventurehub.com/content/dam/bioventurehub/images/meetthecompanies/Oligonova_logo.png/jcr:content/renditions/cq5dam.web.320.Oligonova_logo.png",
      "company_website": "https://oligonova.org/",
      "company_linkedin": "https://www.linkedin.com//company//oligonova-hub//",
      "size_in_visualisation": "medium",
      "image_path": "images/oligonova.png"
    },
    {
      "gruppering": "Device",
      "ecosystem": "BioVentureHub",
      "company_name": "Ondosis",
      "id": "Ondosis",
      "turnover_sek": 19300000,
      "amount_of_employees": 9,
      "type_of_company": "Med Tech, Digital",
      "operationa_focus": "R&D",
      "value_chain": "Market",
      "therapy_areas": "N/A",
      "area": "Dosing",
      "financing": "Private",
      "ceo": "Olovsson, Martin",
      "company_logo": "https://www.azbioventurehub.com/content/dam/bioventurehub/images/logo/Ondosis_new_logo_horiz.jpg/jcr:content/renditions/cq5dam.web.320.Ondosis_new_logo_horiz.jpg",
      "image_path": "images/ondosis.jpg",
      "company_website": "https://www.ondosis.com/",
      "company_linkedin": "https://www.linkedin.com/company/ondosis/",
      "size_in_visualisation": "medium"
    },
    {
      "gruppering": "Diagnostics",
      "ecosystem": "BioVentureHub",
      "company_name": "Profundus",
      "id": "Profundus",
      "turnover_sek": 7800000,
      "amount_of_employees": 7,
      "type_of_company": "Med Tech, Diagnostics",
      "operationa_focus": "R&D",
      "value_chain": "Research",
      "therapy_areas": "Ophthalmology",
      "area": "Analytics",
      "financing": "Private",
      "ceo": "Lindström, Åsa",
      "company_logo": "https://www.azbioventurehub.com/content/dam/bioventurehub/images/logo/Profundus_logo-900x400.jpg/jcr:content/renditions/cq5dam.web.320.Profundus_logo-900x400.jpg",
      "company_website": "https://www.profundusimaging.com/",
      "company_linkedin": "https://www.linkedin.com/company/profundus-ab-sweden/",
      "size_in_visualisation": "medium",
      "image_path": "images/profundus.jpg"
    },
    {
      "gruppering": "Device",
      "ecosystem": "BioVentureHub",
      "company_name": "Promimic",
      "id": "Promimic",
      "turnover_sek": 8400000,
      "amount_of_employees": 13,
      "type_of_company": "Med Tech",
      "operationa_focus": "R&D",
      "value_chain": "Discovery",
      "therapy_areas": "Dental & Orthopaedic",
      "area": "Implants",
      "financing": "Listed",
      "ceo": "Larsson, Magnus",
      "company_logo": "https://media.licdn.com/dms/image/C4D0BAQGNeMDAsSOduw/company-logo_200_200/0/1519917156696?e=2147483647&v=beta&t=-0qaVjnyjDc41bIDrnjUuxdSff7-MfhUYzQKTvESlj4",
      "image_path": "images/Promimic.jpg",
      "company_website": "https://promimic.com/",
      "company_linkedin": "https://www.linkedin.com/company/promimic/",
      "size_in_visualisation": "medium"
    },
    {
      "gruppering": "Digital",
      "ecosystem": "BioVentureHub",
      "company_name": "Synergon",
      "id": "Synergon",
      "turnover_sek": 30400000,
      "amount_of_employees": 7,
      "type_of_company": "Expert Providers",
      "operationa_focus": "Commercial",
      "value_chain": "Market",
      "therapy_areas": "N/A",
      "area": "Intellectual Property",
      "financing": "Private",
      "ceo": "Faijerson Säljö, Jonas",
      "company_logo": "https://www.azbioventurehub.com/content/dam/bioventurehub/images/logo/Synegon_logo.png/jcr:content/renditions/cq5dam.web.320.Synegon_logo.png",
      "image_path": "images/synergon.png",
      "company_website": "https://www.synergon.se/se",
      "company_linkedin": "https://www.linkedin.com/company/synergon_2/",
      "size_in_visualisation": "medium"
    }
  ],
  "links": []
}
